Alkermes Investigational Site

Lauderhill, Florida 33319

0 studies enrolling now · 9 studies all time

What they study most

Bipolar I Disorder, Major Depressive Disorder, Refractory Major Depressive Disorder, Schizophrenia, Schizophreniform Disorder

Studies at this site

• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia — Completed